KALA - Kala Pharmaceuticals Inc. (KALA) CEO Mark Iwicki on Q1 2020 Results - Earnings Call Transcript
Kala Pharmaceuticals, Inc. (KALA)
Q1 2020 Earnings Conference Call
May 7, 2020 8:00 AM ET
Company Participants
Niranjan Kameswaran - Senior Vice President, Strategy
Mary Reumuth - Chief Financial Officer
Mark Iwicki - Chairman, President and Chief Executive Officer
Kim Brazzell - Chief Medical Officer
Todd Bazemore - Chief Operating Officer
Conference Call Participants
Chris Neyor - JP Morgan
Liana Moussatos - Wedbush Securities
Biren Amin - Jefferies LLC
Yi Chen - H.C. Wainwright & Co.
Tazeen Ahmad - Bank of America Merrill Lynch
Presentation
Operator
Good morning, and welcome to Kala Pharmaceuticals’ First Quarter